Genolution

Genolution Book Value per Share

The Book Value per Share of Genolution (225220.KQ) as of Oct 22, 2026 is 3,788.35 KRW. In the previous year, Book Value per Share was 4,446.62 KRW — a change of -14.80% (lower).

Book Value per Share

3,788.35KRW

YoY

-14.80%

Last updated:

Book Value per Share of Genolution is 2025 3,788.35 KRW. Book Value per Share of Genolution was 2024 4,446.62 KRW. It decreases by -14.80% lower compared to the previous year.

The Genolution Book Value per Share history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Book Value per Share
Date
Book Value per Share
Jan 1, 2018
162.77 KRW
Jan 1, 2019
146.14 KRW
Jan 1, 2020
3,394.51 KRW
Jan 1, 2021
4,552.68 KRW
Jan 1, 2022
5,244.73 KRW
Jan 1, 2023
4,843.26 KRW
Jan 1, 2024
4,446.62 KRW
Jan 1, 2025
3,788.35 KRW
The Genolution Book Value per Share history
YEARBook Value per ShareYoY
3,788.35KRW-14.80%
4,446.62KRW-8.19%
4,843.26KRW-7.65%
5,244.73KRW+15.20%
4,552.68KRW+34.12%
3,394.51KRW+2,222.78%
146.14KRW-10.22%
162.77KRW-26.55%
221.60KRW+16.85%
189.64KRW—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Genolution Stock analysis

What does Genolution do? Genolution Inc develops automated nucleic acid extraction devices, nucleic acid extraction reagents, and molecular diagnostic products. The company also offers ribonucleic acid interference services. Its products are distributed domestically and internationally, serving customers in the biotechnology and healthcare sectors. The firm generates revenue through the sale of these products and services to research institutions, laboratories, and healthcare providers. The company's core offerings include nucleic acid extractors, reagents, and diagnostic products, which are used in molecular biology and medical diagnostics. Genolution Inc targets biotech firms, hospitals, and research facilities as key buyers of its technology. Its domestic market presence complements its international distribution channels. Genolution Inc's business model relies on selling its automated extraction devices and reagents to customers requiring efficient nucleic acid processing solutions. The company's molecular diagnostic products cater to healthcare applications, while its ribonucleic acid interference services support advanced research needs. Revenue streams are derived from both product sales and service contracts within the biotechnology industry. Genolution is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Genolution stock

Book Value per Share of Genolution is 3,788.35 KRW in 2025.

Book Value per Share of Genolution changed from 4,446.62 KRW to 3,788.35 KRW, representing a -14.80% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of Book Value per Share Genolution since 2006 – with annual values, charts, and detailed analysis.

Book value per share represents the net asset value of the company per outstanding share. Comparing it to the stock price helps assess whether a stock is undervalued.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Balance Sheet — Genolution

Total AssetsCurrent AssetsCash & EquivalentsReceivablesInventoryProperty, Plant & EquipmentGoodwillIntangible AssetsEquityLiabilitiesDebtCurrent LiabilitiesLong-term DebtShort-term DebtRetained EarningsBook Value per ShareTangible Book Value per ShareWorking CapitalInvestmentsAccounts PayableNon-Current AssetsShort-Term InvestmentsLong-Term InvestmentsNet DebtTreasury StockMinority InterestDeferred Tax LiabilitiesNet Tangible AssetsGoodwill/AssetsIntangibles/Assets

All Key Metrics — Genolution